Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06622044 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 4, 2026 (before its estimated September 7, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Site details revised
    • Study description expanded, about 2 words
    v4
  2. Notable Primary completion date: Sep 7, 2025 to Sep 7, 2026
    • Study completion date: Dec 9, 2025 to Dec 7, 2026
    • Site details revised
    v3
  3. Minor Study description shortened, about 24 words
    • Site details revised
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective, single-center, nonrandomized comparative study evaluates 6-month ocular alignment and binocular visual function outcomes following combined accommodation and fusional training or prism correction in patients with small-angle acute acquired comitant esotropia. Treatment was selected through shared decision-making between the patient and the treating clinician according to the clinical presentation and patient preference.
Trial Details
NCT Number NCT06622044
Lead Sponsor Eye & ENT Hospital of Fudan University
Conditions
(from sponsor)
Esotropia
Related terms Esotropia
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov